Stay updated with breaking news from Prime Editor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 157,952 shares of the firm’s stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $12.74, for a total transaction of $2,012,308.48. Following the sale, the insider now directly owns 10,800,973 shares in the […]
Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 100,772 shares of the firm’s stock in a transaction that occurred on Monday, May 8th. The stock was sold at an average price of $14.13, for a total transaction of $1,423,908.36. Following the sale, the insider now owns 11,421,476 shares of […]
Shares of Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) were down 4.6% during mid-day trading on Friday . The stock traded as low as $14.26 and last traded at $14.43. Approximately 41,304 shares were traded during trading, a decline of 77% from the average daily volume of 181,909 shares. The stock had previously closed at […]
Stifel Nicolaus assumed coverage on shares of Prime Medicine (NYSEARCA:PRME – Get Rating) in a research note released on Monday, The Fly reports. The firm issued a buy rating and a $18.00 price objective on the stock. Separately, Morgan Stanley cut their price target on shares of Prime Medicine from $23.00 to $21.00 and set […]
OUP Management Co. LLC bought a new position in shares of Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 121,255 shares of the company’s stock, valued at approximately $2,253,000. Prime Medicine comprises approximately 3.7% of […]